Great read. I didn't realise there was so much interest in the phase three study, 1000 applications for 212 spots, with the first patients through screening.
I foresee some teething issues the next few months but things are getting juicy, I note the deal with GSK is dependent on CANN being able to demonstrate large scale manufacturing. I wonder if the current set up meets GSK's idea of large scale. I also note there are really not many cannabis companies in Australia with manufacturing capability, I know many of the cultivators use a third party. Who else has a start to finish set up?
Any shareholders who keep a close eye on all the cannabis companies please let us know if GSK sets up provisional arrangements with any of the others.
- Forums
- ASX - By Stock
- Interesting cannabis articles and worldwide updates.
Great read. I didn't realise there was so much interest in the...
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.12M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CAN (ASX) Chart |
Day chart unavailable